Xtant Medical Holdings, Inc. announced the appointment of Scott Neils as Chief Financial Officer, effective June 1, 2022. Mr. Neils has more than 15 years of experience focused on public accounting and corporate finance, and has served as interim Chief Financial Officer since January 3, 2022. Previously, he served as the Company's Controller beginning in August 2019.

In this role, Mr. Neils gained extensive experience managing the Company's finance and accounting functions. Prior to joining Xtant Medical, Mr. Neils served as Audit Senior Manager at Baker Tilly US, LLP (formerly Baker Tilly Virchow Krause, LLP), an advisory, tax and assurance firm, from November 2015 to August 2019. Prior to that position, Mr. Neils was at Grant Thornton LLP, an accounting and advisory organization, from September 2007 to November 2015, most recently as Audit Manager.

Mr. Neils is a Certified Public Accountant. He holds a Bachelor of Science in Business in Accounting and a Master of Accountancy from the Carlson School of Management at the University of Minnesota.